HIV
News
New HIV PrEP guidelines call for clinicians to talk to patients about HIV prevention meds
Conference Coverage
HIV services are bouncing back from COVID-19 disruptions, data suggest, but recovery is ‘precarious’
News
Second woman spontaneously clears HIV: ‘We think more are out there’
Conference Coverage
Updates to CDC’s STI guidelines relevant to midlife women too
An uptick in STIs, especially syphilis, in perimenopausal and postmenopausal women means the new STI recommendations from the CDC are relevant for...
News
COVID-19 causes major interruption in global HIV progress
“We’ve been set back by COVID but we’ve seen remarkable resilience, a lot of innovation and creativity.”
News
Injectable cabotegravir PrEP superior to oral TDF-FTC; trial halted early
“The reason that we were able to show that cabotegravir was superior is because we enrolled a very young, very highly at-risk, very underresourced...
Conference Coverage
When it comes to young women, regular check-ins support ongoing PrEP use
This is important in the U.S. because cisgender Black women make up 60% of all new HIV cases in the U.S. while accounting for just 14% of the U.S...
Conference Coverage
Two-drug dolutegravir treatment noninferior to 3/4 drug regimen
The fixed-dose dolutegravir-based regimen shows noninferiority versus any ART regimens, while also showing feasibility as a first-line treatment...
News
HIV-associated cryptococcal meningitis: Single-dose regimen found non-inferior
Mortality from cryptococcal meningitis with a single-dose regimen of liposomal amphotericin B is similar to the...
Conference Coverage
Twice-a-year lenacapavir shows viral suppression in drug-resistant HIV at 26 weeks
“According to its long half-life of two subcutaneous injections per year, [it] could help reduce pill burden.”